Janukombi Tablet 10/100 mg
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
MFDS item code 202203763 · Approved 2022.10.05
Improvement in blood sugar control
This medication is used in conjunction with diet and exercise to help improve blood sugar control in patients with type 2 diabetes. The combination of sitagliptin and dapagliflozin enhances blood sugar control effects and supports the health management of patients. Therefore, this medication is effective in improving blood sugar control.
This medication may be administered as 1 tablet once daily, regardless of meals, for patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole.
This medication may cause allergic reactions; if symptoms such as skin rash or breathing difficulties occur, discontinue use immediately and consult a doctor. There is a risk of acute pancreatitis during the use of this medication, so if symptoms such as abdominal pain, vomiting, or nausea occur, prompt medical attention is necessary. Patients with certain conditions or reduced kidney function should consult a doctor before using this medication, and dosage adjustments may be required if necessary. For diabetic patients, particularly those taking insulin or sulfonylureas, symptoms of hypoglycemia may occur, so blood sugar should be checked frequently, and appropriate measures should be taken if symptoms arise. This medication may lead to decreased fluid volume or low blood pressure, so caution is required in cases of dehydration, and patients with low blood pressure or those on diuretics should exercise extra caution. There may be an increased risk of genital infections or urinary tract infections, so if infection symptoms occur, inform a doctor immediately. It is advisable for pregnant or breastfeeding women not to use this medication, and if pregnancy is confirmed, discontinue use and consult a doctor. This medication is not recommended for use in children under 18 years of age as safety and efficacy have not been established. Elderly patients may experience impaired kidney function; regular kidney function tests are recommended, and care is needed during use. In case of overdose, seek medical attention immediately for appropriate treatment, as this medication can be removed by dialysis if necessary. During the use of this medication, be cautious of the risk of accidents due to hypoglycemic symptoms when driving or operating machinery. Always take this medication as directed by a physician and report any abnormal symptoms to healthcare professionals immediately.
Urticaria, angioedema, anaphylaxis, exfoliative skin diseases including Stevens-Johnson syndrome, acute pancreatitis, hemorrhagic pancreatitis, necrotizing pancreatitis, severe hypersensitivity reactions, hypotension, severe edema, acute renal failure, severe rash, blisters, skin peeling, oral and ocular mucosal pain, dyspnea, asthma attack, severe respiratory distress, jaundice, liver abnormalities, severe headache, seizures, altered consciousness, visual disturbances, paralysis, decreased urine output
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air and moisture. Additionally, it is recommended to store the medication at room temperature, between 1 and 30 degrees Celsius.
Yellow rectangular film-coated tablet
PTP - 28 tablets/box [(7 tablets/PTP x 4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.